Moolec Science
MLEC
5 hedge funds and large institutions have $64.9K invested in Moolec Science in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.4K |
| 2 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
+$65.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$10.8K |
| 4 |
Morgan Stanley
New York
|
+$5.38K |
| 5 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
+$2.69K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $51.4K | +$74.4K | +83 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $7.17K | +$10.8K | +12 | New |
|
|
3
Morgan Stanley
New York
| $3.38K | +$5.38K | +6 | New |
|
|
AAS
4
Ameritas Advisory Services
Lincoln,
Nebraska
| $1.7K | +$2.69K | +3 | New |
|
|
ECU
5
Eisler Capital (UK)
London,
United Kingdom
| $1.23K | +$65.4K | +73 | New |
|
|
EC
6
Elequin Capital
New York
| $4 | – | – | – |
|
MLEC Hedge Fund Activity: Q1 2023 in Review
5 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q1 2023, worth a combined $64.9K.
Buyers outnumbered sellers: 5 funds opened new MLEC positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $74.4K.
- 5 institutional investors held Moolec Science (MLEC) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $64.9K of Moolec Science stock for Q1 2023.
- 5 funds opened new Moolec Science positions in Q1 2023 and 0 closed out, a net change of +5 holders.
- The largest Moolec Science buyer in Q1 2023 was Geode Capital Management, an estimated $74.4K added.
Based on aggregated 13F filings for Q1 2023.